Article info
Review
Posterior reversible encephalopathy syndrome (PRES): diagnosis and management
- Correspondence to Dr James D Triplett, Neurology, Concord Hospital, Concord, NSW 2139, Australia; James.triplett{at}health.nsw.gov.au
Citation
Posterior reversible encephalopathy syndrome (PRES): diagnosis and management
Publication history
- Accepted November 23, 2021
- First published January 19, 2022.
Online issue publication
May 17, 2022
Article Versions
- Previous version (19 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- The posterior reversible encephalopathy syndrome: what's certain, what's new?
- Reversible cerebral vasoconstriction syndrome
- Pharmacovigilance during treatment of multiple sclerosis: early recognition of CNS complications
- Thunderclap headache
- Cerebral-autoregulatory dysfunction syndrome
- Controversy of posterior reversible encephalopathy syndrome: what have we learnt in the last 20 years?
- Convexity subarachnoid haemorrhage: a practical guide
- Reversible cerebral vasoconstriction syndrome (RCVS) caused by over-the-counter calcium supplement ingestion
- Postpartum headache: diagnostic considerations
- Postpartum vertebral artery dissection with posterior reversible encephalopathy syndrome